JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265512

Human YY1AP1 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

YY1AP1 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

FLJ10875, FLJ13914, GRNG, HCCA1, Hepatocellular carcinoma susceptibility protein, Hepatocellular carcinoma-associated protein 2, OTTHUMP00000033475, OTTHUMP00000033476, OTTHUMP00000200831, OTTHUMP00000200832, OTTHUMP00000200833, OTTHUMP00000200836, YAP, YY1-associated protein 1, YY1AP, YY1AP1, YYAP1_HUMAN

2 Images
Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512)
  • Sanger seq

Unknown

Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512)

Allele-2 : 1 bp insertion in exon 2.

Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512)
  • Sanger seq

Unknown

Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512)

Allele-1 : 2 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265512-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265512 Human YY1AP1 knockout HeLa cell line", "number":"AB265512-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265512-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265512-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265512 Human YY1AP1 knockout HeLa cell line", "number":"AB265512-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265512-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265512-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265512 Human YY1AP1 knockout HeLa cell line", "number":"AB265512-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265512-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265512 Human YY1AP1 knockout HeLa cell line", "number":"AB265512-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
YY1AP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

YY1AP1 also known as Yin Yang 1-Associated Protein 1 has a molecular weight of approximately 75 kDa. It mainly interacts with the YY1 transcription factor modulating transcriptional activity. Researchers find YY1AP1 expressed in various tissues with higher levels noted in the heart brain and liver. The protein localizes itself in both the nucleus and cytoplasm.
Biological function summary

YY1AP1 affects gene regulation and chromatin remodeling. It forms part of a transcriptional complex that includes YY1 and other cofactors. This complex impacts processes like cell proliferation and differentiation through manipulating transcription. YY1AP1 holds a strong role in influencing cellular homeostasis affecting development and cellular response to stress.

Pathways

YY1AP1 plays a role in pathways involving transcriptional regulation and chromatin dynamics. It participates in the Wnt signaling pathway and the p53 pathway. Within these pathways YY1AP1 associates with proteins like β-catenin and Mdm2 aiding in regulating cell cycle and apoptosis. The interactions show YY1AP1's importance in signal transduction and transcriptional response mechanisms.

YY1AP1 connects to cancer and congenital heart disease. In cancer its interaction with YY1 and other transcription factors suggests a role in tumorigenesis where it affects cell cycle regulation and apoptosis. In congenital heart disease altered expression patterns of YY1AP1 or disruption of its interaction with key proteins like GATA4 could contribute to developmental defects. Understanding YY1AP1's involvement in these conditions might offer insight into therapeutic targets and mechanisms.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com